You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Research & Development
Eli Lilly launches Foundayo weight‑loss pill in the US
Login
Username:

Password:


Related Headlines

FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer

Immedica Pharma gains European approval to extend Efmody use in adrenal insufficiency

Neurocrine agrees acquisition of Soleno Therapeutics

NeuroSense's PrimeC composition receives Brazilian patent

Lilly's Foundayo (orforglipron) weight loss pill gains US FDA approval

Parnell launches first FDA-approved generic florfenicol and flunixin combination for bovine respiratory disease

Abbisko Therapeutics' FGFR4 inhibitor irpagratinib granted orphan designation in Europe for HCC

US FDA approves i-Lumen Scientific's i-SIGHT2 clinical study for dry AMD

Lilly to acquire Centessa Pharmaceuticals for up to USD47 per share

ALK secures EU approval for EURneffy 1 mg as needle-free adrenaline option for children

Sanofi secures EU approval for Rezurock in chronic graft-versus-host disease

Boston Scientific receives FDA clearance for Asurys fluid management system

Aurinia Pharmaceuticals agrees to acquire Kezar Life Sciences

Rocket Pharmaceuticals secures FDA approval for Kresladi gene therapy in severe LAD-I

Pharming receives positive CHMP opinion for Joenja marketing authorisation

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026